JANX vs PEAK
Janux Therapeutics Inc (JANX) versus PEAK (PEAK) — a side-by-side from cached financials, not a winner call.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
PEAK (PEAK) common stock.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
PEAK does not have a complete income-statement cache yet.
JANX currently screens at market cap $1.49B.
Not investment advice. Open the JANX and PEAK stock pages for the full models.
Not investment advice.